Gene expression alterations in human prostate cancer

Drugs of Today

Volumn 38, Issue 10, 2002, Pages 713-719

  Luo, Jian Hua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GENETICS; CANCER RECURRENCE; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; GENE EXPRESSION; HUMAN; MALE; METASTASIS; MOLECULAR PROBE; PRECANCER; PREDICTION; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PRECANCEROUS CONDITIONS; PROSTATIC NEOPLASMS;

EID: 0036810972     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2002.38.10.704653     Document Type: Review

References (24)

1. Jemal, A., Thomas, A., Murray, T., Thun, M. Cancer statistics, 2002. CA Cancer J Clin 2002, 52: 23-47.
2. Isaacs, J.T. Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 1997, 150: 1511-21.
3. Dong, J.T., Rinker-Schaeffer, C.W., Ichikawa, T., Barrett, J.C., Isaacs, J.T. Prostate cancer biology of metastasis and its clinical implications. World J Urol 1996, 14: 182-9.
4. Breslow, N., Chan, C.W., Dhom, G. et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 1977, 20: 680-8.
5. Yatani, R., Chigusa, I., Akazaki, K., Stemmermann, G.N., Welsh, R.A., Correa, P. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982, 29: 611-6.
6. Walsh, P.C., Partin, A.W. Family history facilitates the early diagnosis of prostate carcinoma. Cancer 1997, 80: 1871-4.
7. Bova, G.S., Isaacs, W.B. Review of allelic loss and gain in prostate cancer. World J Urol, 1996, 14: 338-46.
8. Elek, J., Park, K.H., Narayanan, R. Microarraybased expression profiling in prostate tumors. In Vivo 2000, 14: 173-82.
9. Bull, J.H., Ellison, G., Patel, A. et al. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br J Cancer 2001, 84: 1512-9.
10. Chaib, H., Cockrell, E.K., Rubin, M.A., Macoska, J.A. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia 2001, 3: 43-52.
11. Chetcuti, A., Margan, S., Mann, S. et al. Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array. Prostate 2001, 47: 132-40.
12. Swinnen, J.V., Vanderhoydonc, F., Elgamal, A.A. et al. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 2000, 88: 176-9.
13. Luo, J., Duggan, D.J., Chen, Y. et al. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling. Cancer Res 2001, 61: 4683-8.
14. Luo, J.H., Yu, Y.P., Cieply, K. et al. Gene expression analysis of prostate cancers. Mol Carcinog 2002, 33: 25-35.
15. Dhanasekaran, S.M., Barrette, T.R., Ghosh, D. et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412: 822-6.
16. Stamey, T.A., Warrington, J.A., Caldwell, M.C. et al. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J Urol 2001, 166: 2171-7.
17. Welsh, J.B., Sapinoso, L.M., Su, A.I. et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001, 61: 5974-8.
18. Singh, D., Febbo, P.G., Ross, K. et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 2002, 1: 203-9.
19. Ernst, T., Hergenhahn, M., Kenzelmann, M. et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: A gene expression analysis on total and microdissected prostate tissue. Am J Pathol 2002, 160: 2169-80.
20. Rubin, M.A., Zhou, M., Dhanasekaran, S.M. et al. Alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002, 287: 1662-70.
21. Bostwick, D.G. Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 1996, 30: 145-52.
22. Bostwick, D.G., Aquilina, J.W. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials. J Cell Biochem 1996, 25(Suppl.): 156-64.
23. Bostwick, D.G., Pacelli, A., Lopez-Beltran, A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996, 29: 117-34.
24. Shah, R., Mucci, N.R., Amin, A., Macoska, J.A., Rubin, M.A. et al. Postatrophic hyperplasia of the prostate gland: Neoplastic precursor or innocent bystander? Am J Pathol 2001, 158: 1767-73.